GGrantIndex
← Leaderboards

Maria Pilar Alcaide Alonso

Tufts University Boston

$8,557,960
Attributed
$8,782,885
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,782,885 · 6

By mechanism

R01$7,321,196 · 3
R00$735,048 · 1
R21$449,850 · 1
K99$276,791 · 1

Top collaborators

Most similar at Tufts University Boston

Same institution · by research overlap

Others in their field

Top investigators on “Inflammatory

Research focus

InflammatoryMediatingInflammationT-LymphocyteResponseHeartAdhesionsCardiacCd4 Positive T LymphocytesIn VitroIn VivoPathway InteractionsCellsHeart FailureHospitalizationImmune ResponseSyndromeMolecularInnovationPhenotypePreventFibrosisFibroblastsNew Therapeutic Target

Grant awards (25)

Regulation of T cell immune response in Heart Failure with Preserved Ejection Fraction$640,781
R01 · FY2025 · HL · contact PI
Regulation of T cell immune response in Heart Failure with Preserved Ejection Fraction$640,498
R01 · FY2024 · HL · contact PI
Regulation of T cell immune response in Heart Failure with Preserved Ejection Fraction$665,693
R01 · FY2023 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$582,638
R01 · FY2023 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$81,505
R01 · FY2023 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$18,947
R01 · FY2023 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$582,638
R01 · FY2022 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$659,412
R01 · FY2021 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$582,638
R01 · FY2020 · HL · contact PI
How Trypanosoma cruzi Transmigrates Through the Vascular Endothelium$245,550
R21 · FY2020 · AI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$53,417
R01 · FY2020 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$36,927
R01 · FY2020 · HL · contact PI
Mechanisms of T cell activation in cardiac fibrosis and non-ischemic heart failure$590,638
R01 · FY2019 · HL · contact PI
How Trypanosoma cruzi Transmigrates Through the Vascular Endothelium$204,300
R21 · FY2019 · AI
T Cell mediated immune responses as a regulator of heart failure$412,500
R01 · FY2018 · HL · contact PI
T Cell mediated immune responses as a regulator of heart failure$412,500
R01 · FY2017 · HL · contact PI
T Cell mediated immune responses as a regulator of heart failure$477,441
R01 · FY2016 · HL · contact PI
T Cell Mediated Immune Responses as a Regulator of Heart Failure$454,287
R01 · FY2015 · HL · contact PI
T Cell Mediated Immune Responses as a Regulator of Heart Failure$16,236
R01 · FY2015 · HL · contact PI
T Cell Mediated Immune Responses as a Regulator of Heart Failure$412,500
R01 · FY2014 · HL · contact PI
Endothelial regulation of IL17 producing T effector cell migration$237,048
R00 · FY2013 · HL · contact PI
Endothelial regulation of IL17 producing T effector cell migration$249,000
R00 · FY2012 · HL · contact PI
Endothelial regulation of IL17 producing T effector cell migration$249,000
R00 · FY2011 · HL · contact PI
Endothelial regulation of IL17 producing T effector cell migration$140,441
K99 · FY2010 · HL · contact PI
Endothelial regulation of IL17 producing T effector cell migration$136,350
K99 · FY2009 · HL · contact PI